MedTrace Logo

Comprehensive Dementia Management : From Translational Medicine to Innovative Care

NCT06214962 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 652

Last updated 2024-03-21

No results posted yet for this study

Summary

The purpose of this stage is to conduct analysis and discussion through expert meetings (consultation) based on the current data of the elderly in each dementia base and Rizhao Center, as well as the weekly courses and activities of the service site (base, Rizhao), and make recommendations.

Conditions

  • Exercise

Interventions

BEHAVIORAL

(multiple training modalities, MTM)

1. Invite experts to discuss the course content of each unit of MTM, and then invite teachers to take pictures , and combine them into one course for the benefit of the elderly in the institution. 2. Select 3 units to try out in the dementia base, and make corrections based on the feedback of the elders and the base staff. 3. Continue to complete other units based on the experience of the first 3 units. (2) In the Rizhao part, experts are mainly used to develop various course modules suitable for the elderly with dementia in Rizhao, and each module unit is tested on the elderly with dementia and then revised The planning task is mainly to establish a solution strategy. The method is to set up an "activity course module planning or design group" to develop various course modules suitable for Rizhao demented elders.

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Li-Jiun Liaw · Kaohsiung Medical University Department of Physical Therapy Associate Professor

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-10
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06214962 on ClinicalTrials.gov